Key result
Younger Pacific Islander, Mexican, and Asian Indian COVID-19 inpatients show similar adjusted mortality to White patients.
Why the study?
COVID-19 data from race/ethnic subgroups remained limited, potentially masking subgroup-level heterogeneity in outcomes.
Do mortality and MACE differ among AAPI and Hispanic subgroups compared with non-Hispanic White patients hospitalized with COVID-19?
Observational (n=13,511)
Yes
Do mortality and MACE differ among AAPI and Hispanic subgroups compared with non-Hispanic White patients hospitalized with COVID-19?
While younger AAPI and Hispanic subgroups are disproportionately hospitalized with COVID-19, their age-adjusted odds of mortality and MACE do not differ from non-Hispanic White patients.
Similar adjusted mortality supports standard inpatient care; leaves open drivers of earlier hospitalization in these subgroups.
BACKGROUND: Coronavirus disease 2019 (COVID-19) data from race/ethnic subgroups remain limited, potentially masking subgroup-level heterogeneity. We evaluated differences in outcomes in Asian American/Pacific Islander (AAPI) and Hispanic/Latino subgroups compared with non-Hispanic White patients hospitalized with COVID-19. METHODS: In the American Heart Association COVID-19 registry including 105 US hospitals, mortality and major adverse cardiovascular events in adults age ≥18 years hospitalized with COVID-19 between March-November 2020 were evaluated. Race/ethnicity groups included AAPI overall and subgroups (Chinese, Asian Indian, Vietnamese, and Pacific Islander), Hispanic/Latino overall and subgroups (Mexican, Puerto Rican), compared with non-Hispanic White (NHW). RESULTS: Among 13,511 patients, 7% were identified as AAPI (of whom 17% were identified as Chinese, 9% Asian Indian, 8% Pacific Islander, and 7% Vietnamese); 35% as Hispanic (of whom 15% were identified as Mexican and 1% Puerto Rican); and 59% as NHW. Mean [SD] age at hospitalization was lower in Asian Indian (60.4 [17.4] years), Pacific Islander (49.4 [16.7] years), and Mexican patients (57.4 [16.9] years), compared with NHW patients (66.9 [17.3] years, p<0.01). Mean age at death was lower in Mexican (67.7 [15.5] years) compared with NHW patients (75.5 [13.5] years, p<0.01). No differences in odds of mortality or MACE in AAPI or Hispanic patients relative to NHW patients were observed after adjustment for age. CONCLUSIONS: Pacific Islander, Asian Indian, and Mexican patients hospitalized with COVID-19 in the AHA registry were significantly younger than NHW patients. COVID-19 infection leading to hospitalization may disproportionately burden some younger AAPI and Hispanic subgroups in the US.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2021) conducted an observational in COVID-19 hospitalization (n=13,511). Asian American/Pacific Islander (AAPI) and Hispanic/Latino race/ethnicity subgroups vs. Non-Hispanic White (NHW) was evaluated on In-hospital all-cause mortality (AAPI overall vs NHW, fully adjusted Model 2) (OR 1.14, 95% CI 0.91-1.41, p=0.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: